Pathophysiological metabolic changes associated with disease modify the proarrhythmic risk profile of drugs with potential to prolong repolarisation-Reference-Cited by-同舟云学术

Pathophysiological metabolic changes associated with disease modify the proarrhythmic risk profile of drugs with potential to prolong repolarisation

Published:2022-01-27 Issue: Volume: Page:
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British J Pharmacology

Author:

TeBay Clifford¹^ORCID,McArthur Jeffrey R.¹²,Mangala Melissa¹³,Kerr Nicholas¹³,Heitmann Stewart¹,Perry Matthew D.¹⁴,Windley Monique J.¹³,Vandenberg Jamie I.¹³,Hill Adam P.¹³^ORCID

Affiliation:

1. Molecular Cardiology and Biophysics Victor Chang Cardiac Research Institute Sydney New South Wales Australia

2. Illawarra Health and Medical Research Institute University of Wollongong Wollongong New South Wales Australia

3. St. Vincent's Clinical School UNSW Sydney Sydney New South Wales Australia

4. School of Medical Sciences UNSW Sydney Sydney New South Wales Australia

Funder

New South Wales Government

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15757

Reference64 articles.

1. The Concise Guide to PHARMACOLOGY 2021/22: Ion channels;Alexander S. P.;British Journal of Pharmacology,2021

2. Hypokalemia in patients with COVID‐19;Alfano G.;Clinical and Experimental Nephrology,2021

3. In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii;Araujo F. G.;European Journal of Clinical Microbiology & Infectious Diseases,1991

4. Torsades de pointes in SARS‐CoV‐2 (COVID‐19) pneumonia: Medicine reconciliation and careful monitoring of QTc interval may help prevent cardiac complications;Aslam W.;BMJ Case Reports,2021

5. Co‐expression of calcium and hERG potassium channels reduces the incidence of proarrhythmic events;Ballouz S.;Cardiovascular Research,2020

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing drug safety by identifying the axis of arrhythmia in cardiomyocyte electrophysiology;eLife;2023-12-11

2. Assessing drug safety by identifying the axis of arrhythmia in cardiomyocyte electrophysiology;eLife;2023-12-11

3. Assessment of the proarrhythmic effects of repurposed antimalarials for COVID-19 treatment using a comprehensive in vitro proarrhythmia assay (CiPA);Frontiers in Pharmacology;2023-08-15

4. Action Potential Morphology Accurately Predicts Proarrhythmic Risk for Drugs With Potential to Prolong Cardiac Repolarization;Circulation: Arrhythmia and Electrophysiology;2023-07

5. Assessing drug safety by identifying the axis of arrhythmia in cardiomyocyte electrophysiology;2023-04-20